How to Buy Sab Biotherapeutics Stock

Sab Biotherapeutics Inc

SAB Biotherapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies.

Sab Biotherapeutics stock last closed at $1.71, down 6.61% from the previous day, and has decreased 47.06% in one year. It has overperformed other stocks in the Biotechnology industry by 0.29 percentage points. Sab Biotherapeutics stock is currently +71% from its 52-week low of $1.00, and -65.87% from its 52-week high of $5.01.

At the moment, there are 9.29M SABS shares outstanding. The market value of SABS is $15.89M. In the past 24 hours, 54,600 SABS shares were traded.

How to Buy Sab Biotherapeutics Stock

Wondering how to invest in Sab Biotherapeutics stock? Here's how.

  1. Decide where to buy Sab Biotherapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you figure out where to buy Sab Biotherapeutics stock.
  2. Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Fund your brokerage account: Select your payment method and add your information.
  4. Research Sab Biotherapeutics stock: The Sab Biotherapeutics ticker symbol is SABS. Is Sab Biotherapeutics stock a good investment? Should you buy shares of SABS? How do SABS's underlying business fundamentals look? Do top analysts think Sab Biotherapeutics is a good buy? Why has SABS's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if SABS is a good stock to buy).
  5. Make your SABS purchase: Decide if you will purchase SABS shares at the current market price or use a limit order to purchase SABS stock at a specific price.
  6. Get updates on your SABS investment: Create a watchlist to watch your new investment in Sab Biotherapeutics shares.

Step 1: Decide where to buy Sab Biotherapeutics stock

You need an online brokerage account to access the NASDAQ market and buy SABS shares.

A brokerage account enables you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our analysis, eToro is the best online stock brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to global markets: From Tech to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've selected your brokerage, the next step is to fill out some personal details so you can invest in SABS today.

How to Open a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal details to create a new trading account.
  1. Send your application by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you've filled out your info on one of the best stock market apps, you can securely and quickly fund your account:

Check out the video below if you need help depositing money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Sab Biotherapeutics stock

Once you have identified the best place to buy Sab Biotherapeutics stock, it's crucial to research their stock before you buy, so you actually understand the risk and upside.

Sab Biotherapeutics Metrics

SABS Price
$1.71
1w %
-5.52%
1y %
-47.06%
5y %
N/A
P/E
-0.46x
P/B
0.74x
P/S
41.71x
PEG
N/A
Revenue
$377.84k
Earnings
-$34.28M
Fore. Rev. Growth
113.3%
Fore. Earn. Growth
N/A
Market Cap
$15.89M
Next Earnings
N/A
Next Dividend
N/A

SABS Overview

WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.

You can see all of the due diligence checks on SABS's stock page.

Is SABS stock properly valued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge SABS's fair value.

Using relative valuations measures:

  • SABS may be undervalued based on its P/B ratio of 0.74x, relative to Biotechnology industry P/B ratio of 4.66x

You can do additional valuation research on SABS's stock here.

A look at SABS Cashflows and Balance Sheet

Pros:

  • There are more short-term assets than long-term liabilities on the SABS balance sheet.
  • There are more short-term assets than short-term liabilities on the SABS balance sheet.

Cons:

  • SABS has cash burn of 31546905. It does not have enough cash and short-term investments to cover this.
  • SABS profit margin has gone down from -1,531.8% to -9,071.8% in the past year.
  • SABS has $12.85M in cash and short term investments. This is not enough to cover its annual cash burn of $31.55M.
  • SABS has a relatively high debt to equity ratio of 0.78.

Is SABS stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 3 Equities analysts who track SABS, the consensus analyst rating on SABS is a Strong Buy

It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are projecting on the Sab Biotherapeutics stock forecast page.

Metrics for Advanced SABS Traders

SMA10
1.84
SMA20
1.83
SMA50
1.65
SMA100
1.79
SMA200
2.5
MACD
0.03
MACD Signal
0.05
MACD Histogram
-0.02
RSI
44.35
Stochastic %K
44.68
Stochastic %D
54.43
StochRSI %K
20.54
StochRSI %D
37.52

SABS Performance Numbers

Last year, SABS revenue was $377.84k. In the past 3 year, SABS's revenue has gone up by -99.77% per year. This was slower than the Biotechnology industry average of 43.24%.

Dig into SABS's earnings and revenue performance here.

What are SABS executives and large shareholders up to?

In the past 12 months, executives and large shareholders at SABS have not bought or sold any shares.

Dig into more about who owns SABS stock here.

Does SABS provide a stable income stream?

No, Sab Biotherapeutics doesn't provide an income stream by paying out dividends.

Get opinions from other investors

One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Make your SABS purchase

You have two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are usually sufficient.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at a given price, use a limit order.

Click the Open button and your broker will execute your order.

If you need additional assistance investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get updates on your SABS investment

Now that you own some shares in SABS, you'll want to keep up with your new stock purchase.

Add SABS to a watchlist to keep track of your SABS stock.

SABS Feed

How to Buy Stock in Sab Biotherapeutics

To reiterate, here are the 6 steps to buy Sab Biotherapeutics stock:

  1. Decide where to buy Sab Biotherapeutics stock
  2. Create a brokerage account
  3. Fund your brokerage account
  4. Research Sab Biotherapeutics stock
  5. Make your SABS purchase
  6. Get updates on your SABS investment

If you need a brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get the latest scoop on your investment in Sab Biotherapeutics, create a watchlist on WallStreetZen today.

NASDAQ: SABS
$1.71-0.12 (-6.61%)
Updated Jun 13, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: SABS
$1.71-0.12 (-6.61%)
Updated Jun 13, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Sab Biotherapeutics share?

As of Jun 13, 2025, it costs $1.71 to buy one share of Sab Biotherapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.86, you can buy 0.5 shares of SABS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Sab Biotherapeutics stock?

According to 3 Wall Street analysts who monitor Sab Biotherapeutics, their consensus recommendation is to buy Sab Biotherapeutics stock.

What is the best way to buy Sab Biotherapeutics stock?

One way to place an order for Sab Biotherapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.